Abstract
Immune escape by cancer cells can be triggered by aberrant expression of immunological key players, which can be achieved by distinct molecular mechanisms including immune modulatory miRNAs. One suitable method to identify miRNAs that specifically target immune relevant molecules is the miRNA enrichment via RNA affinity purification method named miTRAP (miRNA trapping by RNA in vitro affinity purification). Here, we present a detailed protocol for construct preparation, RNA immobilization via MS2BP-MBP to beads, miRNA enrichment, and elution followed by analysis of the obtained miRNA candidates via qRT-PCR.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013
Eichmüller SB, Osen W, Mandelboim O et al (2017) Immune modulatory microRNAs involved in tumor attack and tumor immune escape. J Natl Cancer Inst 109(10). https://doi.org/10.1093/jnci/djx034
Seliger B (2017) Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors. Cytokine Growth Factor Rev 36:49–56. https://doi.org/10.1016/j.cytogfr.2017.07.001
Braun J, Misiak D, Busch B et al (2014) Rapid identification of regulatory microRNAs by miTRAP (miRNA trapping by RNA in vitro affinity purification). Nucleic Acids Res 42(8):e66. https://doi.org/10.1093/nar/gku127
Gao F, Zhao Z, Zhao W et al (2013) miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 431(3):610–616. https://doi.org/10.1016/j.bbrc.2012.12.097
Wang B, Wang Q, Wang Z et al (2014) Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells. Cancer Res 74(20):5746–5757. https://doi.org/10.1158/0008-5472.CAN-13-2563
Xie J, Liu M, Li Y et al (2014) Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. Cell Mol Immunol 11(5):495–502. https://doi.org/10.1038/cmi.2014.30
Wang X, Li J, Dong K et al (2015) Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal 27(3):443–452. https://doi.org/10.1016/j.cellsig.2014.12.003
Kulkarni S, Qi Y, O'hUigin C et al (2013) Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc Natl Acad Sci U S A 110(51):20705–20710. https://doi.org/10.1073/pnas.1312237110
Jasinski-Bergner S, Stoehr C, Bukur J et al (2015) Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma. Oncoimmunology 4(6):e1008805. https://doi.org/10.1080/2162402X.2015.1008805
Cheng Z, Ma R, Tan W et al (2014) MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2. Exp Mol Med 46:e112. https://doi.org/10.1038/emm.2014.51
Chen L, Gibbons DL, Goswami S et al (2014) Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun 5:5241. https://doi.org/10.1038/ncomms6241
Johansson HE, Liljas L, Uhlenbeck OC (1997) RNA recognition by the MS2 phage coat protein. Semin Virol 8(3):176–185. https://doi.org/10.1006/smvy.1997.0120
Chamberlin M, Ring J (1973) Characterization of T7-specific ribonucleic acid polymerase. 1. General properties of the enzymatic reaction and the template specificity of the enzyme. J Biol Chem 248(6):2235–2244
Jurica MS, Licklider LJ, Gygi SR et al (2002) Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA 8(4):426–439
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675
Wang D, Zhang Z, O'Loughlin E et al (2012) Quantitative functions of Argonaute proteins in mammalian development. Genes Dev 26(7):693–704. https://doi.org/10.1101/gad.182758.111
Agarwal V, Bell GW, Nam J et al (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4. https://doi.org/10.7554/eLife.05005
Kertesz M, Iovino N, Unnerstall U et al (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39(10):1278–1284. https://doi.org/10.1038/ng2135
Betel D, Koppal A, Agius P et al (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11(8):R90. https://doi.org/10.1186/gb-2010-11-8-r90
Kramer MF (2011) Stem-loop RT-qPCR for miRNAs. Curr Protoc Mol Biol Chapter 15: Unit 15.10. https://doi.org/10.1002/0471142727.mb1510s95
Chen C, Ridzon DA, Broomer AJ et al (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33(20):e179. https://doi.org/10.1093/nar/gni178
Summer H, Grämer R, Dröge P (2009) Denaturing urea polyacrylamide gel electrophoresis (urea PAGE). J Vis Exp 32:1485. https://doi.org/10.3791/1485
Kedzierski W, Porter JC (1991) A novel non-enzymatic procedure for removing DNA template from RNA transcription mixtures. Biotechniques 10(2):210–214
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Tretbar, U.S., Friedrich, M., Lazaridou, MF., Seliger, B. (2019). Identification of Immune Modulatory miRNAs by miRNA Enrichment via RNA Affinity Purification. In: Pico de Coaña, Y. (eds) Immune Checkpoint Blockade. Methods in Molecular Biology, vol 1913. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8979-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8979-9_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8978-2
Online ISBN: 978-1-4939-8979-9
eBook Packages: Springer Protocols